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Abstract
Background: HIV infection affects multiple organs and the kidney is a common target making renal disease, one of
the recognized complications. Microalbuminuria represents an early, important marker of kidney damage in several
populations including HIV-infected antiretroviral therapy (ART) naïve patients. Early detection of microalbuminuria is
critical to slowing down progression to chronic kidney disease (CKD) in HIV-infected patients, however, the burden
of microalbuminuria in HIV-infected antiretroviral therapy (ART) naïve patients in Uganda is unclear.
Methods: A cross-sectional study was conducted in the Mulago Immune suppression syndrome (ISS) clinic among
adult HIV − infected ART naïve outpatients. Data on patient demographics, medical history was collected. Physical
examination was performed to assess body mass index (BMI) and hypertension. A single spot morning urine sample
from each participant was analysed for microalbuminuria using spectrophotometry and colorimetry.
Microalbuminuria was defined by a urine albumin creatinine ratio (UACR) 30-299 mg/g and macroalbuminuria by a
UACR > 300 mg/g. To assess the factors associated with microalbuminuria, chi-square, Fisher’s exact test, quantile
regression and logistic regression were used.
Results: A total of 185 adult participants were consecutively enrolled with median age and CD4+ counts of
33(IQR = 28–40) years and 428 (IQR = 145–689) cells/μL respectively. The prevalence of microalbuminuria was 18.9%
(95% CI, 14–25%). None of the participants had macroalbuminuria. CD4+ count <350cells/μL was associated with
increased risk of microalbuminuria (OR: 0.27, 95% CI: 0.12–0.59), P value = 0.001). Diabetes mellitus, hypertension,
smoking, alcohol intake were not found to be significantly associated with microalbuminuria.
Conclusion: Microalbuminuria was highly prevalent in adult HIV − infected ART naive patients especially those with
low CD4+ count. There is need to study the effect of ART on microalbuminuria in adult HIV − infected patients.
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Background
The Joint United Nations Programme on HIV and AIDS
(UNAIDS) estimates that at least 40 million people living
with HIV globally and 2.1 million new infections occur-
ring annually in 2014 [1]. Africa bears the world’s HIV
burden of almost 30 million with majority (26.1 million)
in Sub-Saharan Africa (SSA). In Uganda, HIV prevalence
is estimated at 7.3% [1]. HIV infection affects multiple
organs and the kidney is a common target making renal
disease, one of the recognized complications [2–4].
Microalbuminuria represents an early, important
marker of kidney damage and may predict the develop-
ment of proteinuria, a feature of renal disease [5]. It is
crucial, therefore, to identify microalbuminuria as soon
as possible, particularly in this high risk population. The
early detection is vital to slowing down progression to
chronic kidney disease (CKD) among HIV-infected pa-
tients in a Ugandan setting where renal replacement
therapy is not easily accessible.
The occurrence of microalbuminuria in HIV-infected
antiretroviral therapy (ART) naïve patients has not been
explored in Uganda. The purpose of our study was to
determine the prevalence of microalbuminuria in this
adult high risk population and assess any associated fac-
tors using a cross-sectional study.
Methods
Study design and setting
From March 2017 to April 2017, we conducted a cross-
sectional study at Mulago ISS clinic, in Kampala,
Uganda, which attends to a daily average of 5 new HIV
− infected ART naïve patients. Mulago ISS clinic is an
outpatient HIV-clinic at Mulago National Referral Hos-
pital in Kampala, Uganda, which is run by Makerere
University Joint AIDS Program (MJAP). Sample size es-
timation was guided by the using Kish Lesley (1965) for-
mula, assuming a 5% precision, 1.96 level of confidence,
previous prevalence of microalbuminuria of 14% in HIV
[6], giving a size of 185.
Ethics
Ethical approval was obtained from Makerere University
School of Medicine Research and Ethics Committee as
well as administrative permission from Mulago ISS clinic
management to conduct the study. All patients provided
a written informed consent to take part in the study.
Participants
We consecutively enrolled adult out-patients who had a
confirmed positive HIV serological test without prior
ART. Research assistants stationed at Mulago ISS clinic
from Monday to Friday provided information about the
study and obtained informed consent prior to enroll-
ment. We excluded patients with renal disease,
hypertension, diabetes mellitus, menstruating women
and pregnancy. An interviewer-administered structured
questionnaire in a separate enrollment room within in
the clinic was used to collect data on patient demo-
graphics, medical history. Physical examination was per-
formed to assess body mass index (height, weight) and
hypertension.
Data collection and outcome measures
Blood samples were obtained for complete blood count,
liver function tests (Aspartate aminotransferase [AST],
Alanine aminotransferase [ALT], and albumin), serum
urea, serum creatinine and CD4+ count.
Single spot morning urine specimens were obtained in
the morning for urine albumin to creatinine measure-
ment, transported in a cold chain to Mulago hospital la-
boratory and stored at − 80°c. Urine albumin and urine
creatinine were measured using the SELECTRA ProXL®
chemical analyzer (ELITech group solutions, France),
utilizing spectrophotometry and quantitative method of
colorimetric determination of albumin. Microalbumi-
nuria was defined by a urine albumin creatinine ratio
(UACR) 30-299 mg/g and macroalbuminuria by a UACR
> 300mg/g [5].
Statistical analysis
The objective of this research was to determine the
prevalence of microalbuminuria and associated factors
among HIV − infected ART naïve patients at Mulago
Hospital, Kampala, Uganda. For continuous variables i.e.
age and CD4+ count the median and interquartile range
were used to summarize the variables since these were
not normally distributed. Categorical variables were
summarized using frequencies and proportions. The chi-
square and Fisher’s exact test were used to assess the as-
sociation between the categorical variables and outcome.
Conversely, quantile regression was used to assess the
association between the categorical variables and out-
come i.e. microalbuminuria. Variables that were found
to have an association with the outcome were then con-
sidered for the subsequent logistic regression analysis
except for age and sex. Univariate logistic regression was
used to estimate the effect of each explanatory variable
on microalbuminuria. Crudes odds ratios were then ob-
tained and reported. Multivariate logistic regression
models were fitted to estimate the effect of the covari-
ates on the outcome (microalbuminuria) adjusting for
each other and for potential confounders, i.e. age, sex,
CD4+ count and BMI categorized. Each of the explana-
tory variables was added one at a time and those that
were found to be independently associated with the out-
come were then left in the model. For the variables that
were not independently associated with the outcome
were then added back in the model to assess whether
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there was an association between these variables and the
outcome in the presence of other variables. A final
model including age, sex and CD4+ count was then fit-
ted. The Hosmer-Lemeshow test was then used to test
for goodness of fit of the final model and the P-value
(0.437) showed no evidence to reject the null hypothesis
that the fitted model was correctly specified. For this
particular test 20 groups were specified, and explored
observed versus expected values. After fitting the final
model, adjusted ORs and 95% CIs were obtained and re-
ported. All tests were done at 5% level of significance
and analysis was done using Stata version 15.
Results
Characteristics of participants
A total of 185 participants were enrolled in the study.
For these participants, the median age and CD4+ counts
were 33(IQR = 28–40) years and 428 (IQR = 145–689)
cells/μL respectively. 63.8% of them were female and
91.9% were employed in the informal sector. 6.5, 51.3,
and 61.1% of the participants were smokers, had a his-
tory of alcohol consumption, and had normal weight
respectively.
The prevalence of microalbuminuria among these par-
ticipants was 18.9% (95% CI: 14–25%). None of the par-
ticipants had macroalbuminuria. Most (60%) of
participants with microalbuminuria were also single and
had primary education attained as their highest level of
education. Most of these participants, 68.8%, had a
CD4 + count of < 350 cells/μL. (Table 1).
Majority of participants were Christians, not on any
on any concomitant medications, did not have hyperten-
sion or diabetes mellitus (79.5, 78.4, 9.2, and 18.9% re-
spectively). There were no statistically significant
differences in the mean urea and creatinine among par-
ticipants with normal UACR and microalbuminuria {2.5
(0.5) mmol/L and 59.1 (16.0) μmol/L versus 2.8 (1.1)
and 62.3 (28.4)} (p value 0.3 and 0.08) respectively.
Factors associated with microalbuminuria
From the multivariate model: There was solid evidence
(P = 0.001) of an association between CD4+ count and
microalbuminuria after adjusting for sex and age in the
model. Participants with CD4+ count greater than or
equal to 350 cells/μL had lower odds of having this con-
dition as compared to those with CD4+ count less than
350 cells/μL. (OR:0.27, 95% CI: 0.12–0.59). Also, there
was some evidence of an association between sex and
microalbuminuria. Females had higher odds of develop-
ing this condition as opposed to male participants. (OR:
2.61, 95% CI: 1.03–6.61). There was no association (P =
0.292) between age and microalbuminuria after adjusting
for sex and CD4+ count in the model Table 2.
Discussion
The prevalence of microalbuminuria in HIV − infected
ART naïve patients in this study was 18.9% and was as-
sociated with low CD4+ count. Microalbuminuria has
been shown to be one of the early markers for renal in-
jury and an important predictor for both morbidity and
mortality in HIV − infected patients [5, 7]. This study
has provided the prevalence of microalbuminuria and its
associated factors which had not been well established
among ART naïve adult patients in Uganda.
This study looked at HIV − infected ART naïve patients
attending the Mulago ISS clinic and the prevalence of
microalbuminuria reported was different from most of the
studies conducted in recent times [5, 6, 8–14]. It was chal-
lenging to compare this study with those conducted earl-
ier due to several factors which include differing study
participants and sample sizes, in addition to varying assay
techniques and methodologies.
The most recent and similar study done in Tanzania
[14] found prevalence at 20.4% which is close to that
demonstrated by our study (18.9%) though it assessed
HIV − infected children. However, a study from South
Africa [8] found the prevalence of microalbuminuria at
24.0%. They included in-patients, who are known to be
at higher risk of microalbuminuria due to advanced HIV
[15] compared to ambulatory patients and this could ex-
plain the higher prevalence. Another study [13] demon-
strated that advanced HIV disease was significantly
associated with microalbuminuria. They found a higher
prevalence of microalbuminuria at 28.8% but included
participants on ART. In the same study, they demon-
strated that recent ART was associated with microalbu-
minuria. This too was demonstrated in USA [6] that
patients who were recently ritonavir were more likely to
have microalbuminuria compared to those who were not
on ritonavir (19.8 vs.7.4%).
The only study done in Africa that looked at partici-
pants with similar characteristics (adult HIV ART naïve
patients attending an outpatient clinic) was in Tanzania
[10] demonstrated the higher prevalence of microalbu-
minuria at 70.2%. In this study, they used dipsticks and
the patients had relatively lower mean CD4+ count com-
pared to our study (200 versus 466 cells/μL).
Notably, there were two studies in adults that demon-
strated lower prevalence 8.9% [12] in Democratic Repub-
lic of Congo(DRC) and 14% [6] in USA having included
both ART experienced and ART naïve patients. Other
studies that have found lower prevalence (less than 19%
in our study) were conducted among HIV − infected Ni-
gerian children reported prevalence of microalbuminuria
of 11.1 and 12% [9, 11]. Overall, the differences in
screening methodologies and the clinical characteristics
of study participants probably explain the varied results
among studies in relation to our study.
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Factors associated with microalbuminuria
We found that low CD4+ count (<350cells/μL) was in-
dependently associated with microalbuminuria. Several
studies have shown microalbuminuria being associated
with reducing CD4 + counts. Our study looked at CD4+
count as continuous variable with microalbuminuria be-
ing associated with lower mean CD4+ count compared
to normal UACR (320 versus 500cells/μL). A prospective
cohort study [6] demonstrated that those with microal-
buminuria were more likely to have a CD4 count < 200
cells/μL. In our study, when CD4 + count was analysed
as a categorical variable, those with microalbuminuria
were more likely to have CD4 + count < 350 cells/μL
even after adjusting for age and sex. The scientific ex-
planation for the relationship between microalbuminuria
and low CD4 + counts has not been fully explained. It is,
however, likely that our study participants who had low
CD4 + counts did have more advanced disease and likely
to have had early or even overt HIVAN.
The relationship between microalbuminuria and
underweight has not been established among adult HIV
− infected patients. In our study, microalbuminuria was
associated with being underweight, a finding that was
evident in other populations [13, 16, 17]. However, our
study may not have been powered enough to ascertain
these relationships.
Limitations
Although our study did not find significant association
between other factors such as hypertension, diabetes
mellitus age, sex, alcohol use and smoking with microal-
buminuria, we did not assess the association between
Table 1 Baseline demographic and clinical characteristics of study participants (N = 185)
Variable Normal UACR Microalbuminuria Total P-value
Age in years, median(IQR) 33 (28–40) 34 (26–40) 33 (28–40) 0.658
CD4+ count (cells/μL), median(IQR) 460 (215–731) 215 (84–539) 428 (145–689) 0.007
Sex
Male 59 (39.3) 8 (22.9) 67 (36.2)
Female 91 (60.7) 27 (77.1) 118 (63.8) 0.080*
Occupation
Informal 137 (91.3) 33 (94.3) 170 (91.9)
Formal 13 (8.7) 2 (5.7) 15 (8.1) 0.740*
Highest level of education
None 14 (9.3) 0 (0.0) 14 (7.6)
Primary 70 (46.7) 21 (60.0) 91 (49.2)
Secondary 49 (32.7) 13 (37.1) 62 (33.5)
Tertiary 17 (11.3) 1 (2.9) 18 (9.7) 0.079*
Marital Status
Married 58 (38.7) 10 (28.8) 68 (36.8)
Single 77 (51.3) 21 (60.0) 98 (53.0)
Widowed 6 (4.0) 0 (0.0) 6 (3.2)
Others 9 (6.0) 4 (11.4) 13 (7.0) 0.327*
History of Alcohol consumption
Yes 76 (50.7) 19 (54.3) 95 (51.3)
No 74 (49.3) 16 (45.7) 90 (48.7) 0.700
History of smoking
Yes 9 (6.0) 3 (8.6) 12 (6.5)
No 141 (94.0) 32 (91.4) 173 (93.5) 0.701*
BMI in Kg/m2
Underweight 12 (8.0) 9 (25.7) 21 (11.4)
Normal 93 (62.0) 20 (57.1) 113 (61.1)
Overweight 26 (17.3) 5 (14.3) 31 (16.8)
Obese 19 (12.7) 1 (2.9) 20 (10.8) 0.020*
P-value*: fishers exact p-value
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microalbuminuria and viraemia due to financial con-
straints yet it has been cited as a predictor of microalbu-
minuria [5]. Hypertension was defined by two blood
pressure readings of a systolic ≥140mmHg and diastolic
≥90mmHg taken 30 min apart. This was not the best
method but the most feasible for an out-patient clinic.
Conclusion
The prevalence of microalbuminuria in HIV − infected
ART naïve patients was 18.9% and the associated low
CD4+ count. This study has enlightened the magnitude of
the earliest form of renal dysfunction in HIV − infected
ART naïve patients and therefore screening for microalbu-
minuria should be advocated for before ART initiation.
Recommendations
HIV − infected patients with CD4+ count < 350 cells/μL
may need to be screened for microalbuminuria before
ART initiation.
There is need for further assessment of the relation-
ship between underweight and microalbuminuria in a
larger study.
There is need for further assessment of the progres-
sion of microalbuminuria in HIV patients after initiation
of ART.
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